- Patent Title: STAT3 transcription factor inhibitors and methods of using the same
-
Application No.: US17311021Application Date: 2019-12-06
-
Publication No.: US11952353B2Publication Date: 2024-04-09
- Inventor: Philip Reigan , Donald S. Backos , Christopher J. Matheson , Steffanie L. Furtek , Craig T. Jordan , Maria L. Amaya
- Applicant: The Regents of the University of Colorado, A Body Corporate
- Applicant Address: US CO Denver
- Assignee: The Regents of the University of Colorado
- Current Assignee: The Regents of the University of Colorado
- Current Assignee Address: US CO Denver
- Agency: Snell & Wilmer L.L.P.
- International Application: PCT/US2019/065085 2019.12.06
- International Announcement: WO2020/118265A 2020.06.11
- Date entered country: 2021-06-04
- Main IPC: C07D263/57
- IPC: C07D263/57 ; C07C205/43 ; C07C233/66 ; C07C235/64 ; C07D233/26 ; C07D263/32 ; C07D307/16 ; C07D307/54 ; C07D307/56 ; C07D307/58 ; C07D307/66 ; C07D307/68 ; C07D307/80
Abstract:
Compounds that inhibit the activity of Signal transducer and activator of transcription 3 (STAT3), or pharmaceutically acceptable salts or prodrugs thereof, and methods of using these compounds to treat cancer and other diseases.
Public/Granted literature
- US20220017476A1 STAT3 TRANSCRIPTION FACTOR INHIBITORS AND METHODS OF USING THE SAME Public/Granted day:2022-01-20
Information query
